Protalix BioTherapeutics (PLX) Non-Current Deffered Revenue (2010 - 2022)
Protalix BioTherapeutics (PLX) recorded Non-Current Deffered Revenue of $5.9 million in Q2 2022, up 364.5% from $1.27 million a year earlier and unchanged from the prior quarter.
Powered by 
Analysis
Protalix BioTherapeutics (PLX) Non-Current Deffered Revenue (2010 - 2022) Analysis & Trends
At the end of FY2021, Protalix BioTherapeutics reported Non-Current Deffered Revenue of $11.79 million, up 587.1% from FY2020.
- Annual Non-Current Deffered Revenue has a four-year compound annual growth rate of -17.1% (FY2017 to FY2021).
- Across earlier years, Non-Current Deffered Revenue came in at $1.72 million in FY2020 (-89.9%), $16.98 million in FY2019 (-48.6%), $33.03 million in FY2018 (+32.0%) and $25.02 million in FY2017.
- Quarterly Non-Current Deffered Revenue has ranged from $858,000 in Q1 2021 to $34.91 million in Q2 2019 over the past five years.
- On a year-over-year basis, Non-Current Deffered Revenue has increased for four consecutive quarters, with growth averaging 185.2% over the last eight quarters.
- Peak year-over-year performance for Non-Current Deffered Revenue in the last five years was growth of 587.1% in Q1 2022, against a decline of 94.6% in Q3 2020 at the low end.
- Per Business Quant, the preceding three quarters came in at $5.9 million (Q1 2022), $11.79 million (Q4 2021) and $5.9 million (Q3 2021).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Deffered Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,137.66 Bn | 1,106.24 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 636.13 Bn | 556.00 Bn | 17.30 Bn | - |
| 3 | AbbVie | 505.28 Bn | 478.39 Bn | 12.70 Bn | - |
| 4 | Merck | 358.10 Bn | 312.48 Bn | 12.21 Bn | - |
| 5 | Novartis Ag | 292.59 Bn | 256.58 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 265.81 Bn | 239.50 Bn | 12.86 Bn | - |
| 7 | Amgen | 237.53 Bn | 192.93 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn | - |
| 9 | Pfizer | 171.17 Bn | 117.82 Bn | 10.94 Bn | - |
| 10 | Protalix BioTherapeutics | 204.37 Mn | 52.98 Mn | 12.13 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2022 | 5.90 Mn |
| Mar 31, 2022 | 5.90 Mn |
| Dec 31, 2021 | 11.79 Mn |
| Sep 30, 2021 | 5.90 Mn |
| Jun 30, 2021 | 1.27 Mn |
| Mar 31, 2021 | 858,000.00 |
| Dec 31, 2020 | 1.72 Mn |
| Sep 30, 2020 | 1.53 Mn |
| Jun 30, 2020 | 4.12 Mn |
| Mar 31, 2020 | 7.13 Mn |
| Dec 31, 2019 | 16.98 Mn |
| Sep 30, 2019 | 28.59 Mn |
| Jun 30, 2019 | 34.91 Mn |
| Mar 31, 2019 | 32.98 Mn |
| Dec 31, 2018 | 33.03 Mn |
| Sep 30, 2018 | 33.49 Mn |
| Jun 30, 2018 | 21.64 Mn |
| Mar 31, 2018 | 22.38 Mn |
| Dec 31, 2017 | 25.02 Mn |
| Sep 30, 2016 | 453,000.00 |
API Access
Protalix BioTherapeutics Non-Current Deffered Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=PLX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-deffered-revenue", "ticker": "PLX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=PLX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();